LEADER 01350nam  2200421Ia 450 
001 9910699222803321
005 20230902161935.0
035   $a(CKB)5470000002401681
035   $a(OCoLC)493452069
035   $a(EXLCZ)995470000002401681
100   $a20091223d1995      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aPharmacokinetics$b[electronic resource] $eguidance for repeated dose tissue distribution studies
210  1$a[Rockville, MD] :$c[U.S. Dept. of Health and Human Services, Food and Drug Administration],$d[1995]
215   $a1 online resource (i, 3 pages)
225 1 $aGuideline for industry ;$vICH-S3B
300   $a"March 1995."
320   $aIncludes bibliographical reference (page 3).
410  0$aGuideline for industry ;$vICH-S3B.
517   $aPharmacokinetics 
606   $aPharmacokinetics
606   $aTissues
606   $aDrugs$xTesting
615  0$aPharmacokinetics.
615  0$aTissues.
615  0$aDrugs$xTesting.
712 02$aUnited States.$bFood and Drug Administration.
712 12$aInternational Conference on Harmonisation.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910699222803321
996   $aPharmacokinetics$91022895
997   $aUNINA